Martek Biosciences Corp. - Aggressive Growth - Zacks Rank Buy
Zacks Market Commentaries (October 19th, 2008) Writes:
The deal allows Martek to continue its international expansion into Mexico, Europe, and China. Martek's proprietary DHA and ARA blend is used in approximately 95% of infant formulas sold in the U.S.
On Sep 4 Martek announced third-quarter earnings that included earnings per share of 28 cents. This market the fourth surprise in the past 4 quarters, as analysts were only expecting 24 cents. Revenues rose 14% year-over-year to $88.4 million.
Martek also raised full-year guidance during the announcement. The company expects earnings per share to be between $1.06 and $1.09,
...beauty retailer, cents, China, Cosmetics & Fragrance Inc., Europe, food, Grupo Ricap, Hero, Hochdorf Nutricare, Martek Biosciences Corp, Mexico, Perrigo Company, Revlon Inc., Stocks to Watch, United States, USD, Zhongpin Inc.


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)





